第一作者论文

1、Zhu X#, Wang X#,Wei S, Chen Y, Chen Y, Fan X, Han S, WG*.hsa_circ_0013958: acircular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J.2017,284(14):2170-2182.IF=4.739

2、Wang X#, Zhu X#,Zhang H, Wei S, Chen Y, Chen Y, Wang F, Fan X, Han S, Wu G*.Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promotelung adenocarcinoma proliferation. Biochem Biophys Res Commun.2018,496(4):1069-1075. IF=2.705

3、H Wang#, XL Zhu#*,JHuang, PS Chen,SH Han, Y Xie. Nedaplatin Sensitization

Cisplatin-resistant Human Non-small Cell Lung Cancer Cell Lines.Oncology Letters. 2016,11:2566-72. IF=1.871

4、Q Zhang#, XL Zhu#*,L Zang, SQ Sun,J Huang, Y Lin. A prospective study of biomarker-guidedchemotherapy in patients with non-small-cell lung cancer. Cancer ChemotherPharmacol. 2014,74(4):839-46. IF=3.008

5、XL Zhu#, XC Sun*, BAChen*, N Sun, HY Cheng, F Li, H Zhang, JF Feng, S Qin, L Cheng, Z Lu. XPCLys939Gln polymorphism is associated with the decreased response to platinumbased chemotherapy in advanced non-small-cell lung cancer. Chinese MedicalJournal. 2010,123(23):342734-32.IF=1.555

通讯作者论文

1、Hua Xin., Zhang Hongming., Jia Jinfang., Chen Shanshan., Sun Yue., Zhu X*. Roles of S100      family members in drug resistance intumors: Status and prospects.[J] .Biomed Pharmacother, 2020, 127: 110156.IF=4.545

2、Chen Shanshan., Chen Jing., Hua Xin., Sun Yue., Cui Rui., Sha Jun., Zhu X*. The emerging role of XBP1in cancer.[J] .Biomed Pharmacother, 2020, 127: 110069.IF=4.55

3、Han SH*,Cao DD,Sha J,Zhu XL*,ChenDQ. LncRNA ZFPM2‐AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to de‐stabilizeZFPM2. Molecular  Oncology.[J].2020.1878-0261.12631.IF=6.574  

4、郭献平,朱晓莉.肺结节患者临床特征及情绪研究进展[J].东南大学学报(医学版),2020,39(05):688-692.

5、贾金芳,黄静,朱晓莉.肿瘤相关自身抗体对恶性肺结节的诊断价值[J].中国肿瘤临床,2020,47(06):271-276.

6、 Chen J, Liu X, Xu Y, Zhang K, Huang J3, Pan B, Chen D, Cui S, Song H,Wang R, Chu X, ZhuX*, Chen L*.TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-ResistantLung Adenocarcinoma Cells. Mol Ther Nucleic Acids. 2019,14:567-582. IF=5.919

7、Zhang H, Chen R, Wang X, Zhang H, Zhu X*, Chen J. Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPKActivation Through ROS Generation in Non-Small-Cell Lung Cancer. Front Oncol.2019,9:538. IF=4.137

8、Hua X, Sun Y, Chen J, Wu Y, Sha J, Han S, Zhu X*. Circular RNAs in drug resistant tumors. Biomed Pharmacother.2019,118:109233. IF=3.743

9、Hua X, Chen J, Wu Y, Sha J, Han S, ZhuX*. Prognostic role of the advanced lung cancer inflammation index incancer patients: a meta-analysis. World J Surg Oncol. 2019,17(1):177. IF=1.966

10、Hua X, Han SH, Wei SZ, Wu Y, Sha J, Zhu XL*. Clinicalfeatures of pulmonary embolism in patients with lung cancer: A meta-analysis.PLoS One. 2019,14(9):e0223230. IF=2.776

11、Wu H, You C, Jiao J, Chen F, Sun B, Zhu X*. A novel near-infrared triggered dual-targeted nanoplatform formitochondrial combined photothermal-chemotherapy of cancer in vitro.Nanotechnology. 2019,30(3):035601. IF=3.399

12、华欣,孙岳,朱晓莉.环状RNA在肺腺癌中的差异表达分析[J].东南大学学报(医学版),2019,38(06):1019-1023.

13、许露,朱晓莉,王欢,韩淑华,黄亭亭.藤黄酸对顺铂诱导A549/DDP细胞凋亡的增敏作用[J].东南大学学报(医学版),2019,38(03):438-444.

14、     丁明,袁成,李萍,黄静,朱晓莉.稳定期慢性阻塞性肺疾病患者肺泡灌洗液中IL-8、IL-17水平的相关性研究[J].南京医科大学学报(自然科学版),2019,39(06):884-889.

15、华欣,丁明,朱晓莉.支气管热成形术在极重度支气管哮喘人群中的应用[J].国际呼吸杂志,2019(02):119-123.

16、华欣,朱晓莉.非小细胞肺癌中Ang-2相关研究进展[J].中国肺癌杂志,2018,21(11):868-874.

17、Huang T, Zhang H, Wang X, Xu L, Jia J, Zhu X*. Gambogenic acid inhibits the proliferation of small‑celllung cancer cells by arresting the cell cycle and inducing apoptosis. OncolRep. 2018 Dec 21. [Epub ahead of print]. IF=3.041

18、Wei S, Wu T, Wu Y, Ming D, ZhuX*. Diagnostic accuracy of Candida albicans germ tube 

antibody for invasive candidiasis:systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2018 Nov 6.[Epub ahead of print]. IF=2.314

19、 Chen Y, Wei S, Wang X, ZhuX*, Han S*. Progress in research on the role of circular RNAs in lungcancer. World J Surg Oncol. 2018,16(1):215. IF=1.966

20、Wu Y, Ding M, Wei S, Wu T, Xu R, Zhu X*, Liu H*. The prognostic value of long noncoding 

RNA ZEB1-AS1 on clinical outcomes in humancancer. J Cancer. 2018,9(20):3690-3698. IF=3.182

21、 Ding S, Xiong J, Lei D, Zhu XL*, Zhang HJ*. Recombinant nanocomposites by the clinical

drugs of Abraxane® and Herceptin® assequentially dual-targeting therapeutics for breast cancer. J Cancer.2018,9(3):502-511. IF=3.182

22、Huang Jing, Zhu Xiaoli*,Wang Huan, Han Shuhua, Liu Lu, Xie Yan, Chen Daozhen, Zhang

Qiang,Zhang Li, Hu Yue. Role of gambogicacid and ¹³¹I in A549/DDP cells. Oncology Letters. 2017,13:37-44. IF=1.871

23、 Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H,Zhu X*, Chen B*. Lobaplatin for thetreatment of SK-MES-1 lung squamous cell line in vitro and in vivo. OncoTargets Ther.2016,11(9):4215-24. IF=3.046

24、H Wang#, XL Zhu#*,J Huang, PS Chen,SHHan, Y Xie. Nedaplatin Sensitization of Cisplatin-resistant Human Non-smallCell Lung Cancer Cell Lines. Oncology Letters. 2016,11:2566-72. IF=1.871

25、H Wang, J Huang, XJ Yu, SH Han, X Yan, SQ Sun, XL Zhu*. Different efficacy of EGFR tyrosine kinase inhibitors andprognosis in patients with subtypes of EGFR-mutated advanced 

non-small-cell lung cancer: ameta-analysis. J Cancer Res Clin Oncol. 2014,140(11):1901-09. IF=3.332

26、 Q Zhang#, XLZhu#*, L Zang, SQ Sun,J Huang, Y Lin. A prospective study ofbiomarker-guided chemotherapy in patients with non-small-cell lung cancer.Cancer Chemother Pharmacol. 2014,74(4):839-46. IF=3.008

专著

1.《内科学诊治进展》.军事医学科学出版社，北京，2008年12月第一版，参编

2.《内科医师查房手册》.军事医学科学出版社，北京，2013年6月第一版，副主编

授权发明专利

朱晓莉，王西勇，张洪明，韩淑华，陈燕，陈阳 一组用于肺腺癌早期诊断的circRNA标志物及其应用，中国，公开（公告）号：CN106434928B，公开（公告）日：2019-12-31

获得学术奖励

1、朱晓莉（3/3），《支气管肺泡灌洗液CEA、β2-MG测定对肺癌诊断的临床应用》省级成果（95苏卫鉴字23号）；铁道部，科技进步四等奖，1996

（张祖贻，刘璐，朱晓莉）

2、朱晓莉（4/7）《联合测定胸水LDH、LZM、ADA鉴别良恶性胸水的临床研究》 省级成果（95苏卫鉴字31号）；江苏省卫生厅，1995

（李基业、张祖贻、骆益民、朱晓莉、林勇、赖启明、周贤梅）

3、朱晓莉（5/7）《雷公藤多甙对哮喘IL-5、ICAM-1及其mRNA表达的影响》省级成果 （苏科鉴字2003第772号）,南通市科技局，科技进步二等奖，2005

（张祖贻、王西华、杨远、金淑贤、朱晓莉、骆益民、尹静萍）

4、朱晓莉（8/15）孤立性肺结节的螺旋CT动态增强研究》省级成果 （苏科鉴字2004第777号）；江苏省科技厅，科技进步三等奖，2005

（储成凤、徐秋贞、刘斌、杨明、陈峰、姚青、张俭、朱晓莉、朱亚彬、杨小庆、郏爱明、方丽、秦伟、陈龙桂、藤皋军）

5、朱晓莉（1/1）《南京市第九届自然科学优秀学术论文奖》；题目：藤黄酸诱导非小细胞肺癌细胞凋亡的机制及其与转铁蛋白受体的关系；南京市自然科学优秀学术论文评审委员会，2011；

（朱晓莉）

6、朱晓莉（1/1）《南京市第九届自然科学优秀学术论文奖》；题目：非小细胞肺癌患者XPC基因Lys939Gln多态性与铂类药物为主化疗疗效相关； 南京市自然科学优秀学术论文评审委员会，2011；

（朱晓莉）

7、朱晓莉（1/1）《薏苡仁酯联合化疗治疗非小细胞肺癌的临床研究》，江苏省卫生厅科技发展基金会科研优秀项目（江苏省卫生厅科教处、江苏省医学会肿瘤化疗与生物治疗分会），优秀项目，2013；

（朱晓莉）